For much of the past few years, CVS was treated as a problem stock. But new earnings show a promised comeback is actually ...

CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

Accounting for 13.76% share ($617.96 million) in the billionaire’s portfolio, CVS Health Corporation (NYSE:CVS) ranks as ...

CVS Q4 earnings preview: analysts see profit down 16% as revenue rises. Learn EPS/revenue forecasts, revisions, and outlook—read before Feb.

CVS Health had another solid quarter. The company, which is emerging from a yearslong turnaround, reported an 8% increase in ...

CVS Health Corporation (NYSE:CVS) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. On January ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

Current CVS Health CEO David Joyner took over a little over a year ago. The company's growth rate has been improving and its overall financial results have been stronger. The stock's rally has put it ...

CVS Health Corporation (NYSE:CVS) is one of the stocks in focus on Jim Cramer’s game plan. Cramer highlighted the stock’s ...

CVS Health has been a volatile investment to own in recent years, skyrocketing in 2025 after crashing in 2024. Rising costs have been weighing on investors' minds, but CVS has been doing better than ...